Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)
NCT03430869
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
F-18 AV-45
DRUG:
F-18-THK-5351
Sponsor
Chang Gung Memorial Hospital